Patient Ancestry Questionnaires for Transplant
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a person's background and economic status might affect their choice and success with bone marrow transplants. It examines whether individuals receive genetically similar (closer match) bone marrow. Participants will complete a questionnaire about their family background, and researchers will use medical records to track health outcomes. Eligible participants are those planning to undergo a bone marrow transplant. As an unphased trial, participation offers a unique opportunity to contribute to understanding how personal factors influence transplant success.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to uncover disparities in the provision of allogeneic bone marrow transplantation, a key treatment for various blood cancers and disorders. Unlike most studies that focus on the medical aspects alone, this trial digs into social and demographic factors to see how they influence access to this life-saving treatment. By collecting detailed information on participants' demographics and health outcomes, researchers hope to identify and address barriers, ensuring more equitable access to transplantation for all patients. This could lead to significant improvements in healthcare fairness and outcomes.
Who Is on the Research Team?
Warren Fingrut, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Consent and Questionnaire
Participants sign the consent form and complete a questionnaire about their demographic information and ancestry
Data Collection
Information about the participants' medical history, choice of bone marrow donor, and health outcomes is collected from medical records
Follow-up
Participants are monitored for safety and effectiveness after transplantation
What Are the Treatments Tested in This Trial?
Interventions
- Patient Ancestry Questionnaires
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants are expected to be in this research study for up to 2 years after the participants bone marrow transplantation. However, your active participation will only last 1 day, when you sign the consent form and complete a questionnaire about your demographic information and ancestry (family ethnicity). For the rest of the study, information about the participants medical history, choice of bone marrow donor, and health outcomes will be collected from your medical record.
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.